Atyr Pharma Inc (ATYR)

11:00 AM

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Benzinga

11:00 AM

08:54 AM

aTyr Pharma Soars 11.26% on Phase 3 Study Completion - AInvest

08:54 AM

08:01 AM

aTyr Pharma stock holds Buy rating as Phase 3 trial completes - Investing.com Canada

08:01 AM

05:39 AM

Is aTyr Pharma Inc. a good long term investmentRecord-breaking gains - Autocar Professional

05:39 AM

02:15 AM

What analysts say about aTyr Pharma Inc. stockMarket-leading capital gains - Autocar Professional

02:15 AM

Jul 22, 2025

aTyr Pharma Announces Last Patient Visit in Phase 3 - GlobeNewswire

Jul 22, 2025

Jul 22, 2025

What drives aTyr Pharma Inc. stock priceMarket-beating returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

aTyr Pharma Inc. Stock Analysis and ForecastFree Risk Assessment Services - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

aTyr Pharma Reaches US$515m Market Cap Benefiting Insider Stock Buying - simplywall.st

Jul 19, 2025

Jul 18, 2025

aTyr Pharma, Inc. (NASDAQ:ATYR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 18, 2025

Jul 18, 2025

RNA Therapeutics and RNA Vaccines Market Industry Report 2025-2035: Investments in RNA Technologies Surge with USD 2.9 Billion Funding - GlobeNewswire Inc.

Jul 18, 2025

Jul 16, 2025

What makes aTyr Pharma Inc. stock price move sharplyFree Stock Trading Community - beatles.ru

Jul 16, 2025

Jul 15, 2025

How aTyr Pharma Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025

Jul 15, 2025

Why aTyr Pharma Inc. stock attracts strong analyst attentionProven Win Setups - Newser

Jul 15, 2025

Jul 14, 2025

Can ATyr's EFZO-FIT Data Help Patients And Investors Breathe Easier? - RTTNews

Jul 14, 2025

Jul 11, 2025

Pulmonary Sarcoidosis Market on Track for Major Expansion - openPR.com

Jul 11, 2025

Jul 11, 2025

Pulmonary Sarcoidosis Market on Track for Major Expansion by 2032, According to DelveInsight | aTyr Pharma, Kinevant Sciences, Novartis, aTyr Pharma, Novartis Pharma, Mallinckrodt - Barchart.com

Jul 11, 2025

Jul 07, 2025

Favourable Signals For aTyr Pharma: Numerous Insiders Acquired Stock - Yahoo Finance

Jul 07, 2025

Jul 07, 2025

aTyr Pharma: Insider Buys and Russell 2000 Inclusion Signal a Rare Buying Opportunity - AInvest

Jul 07, 2025

Jul 06, 2025

Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying - MSN

Jul 06, 2025

Jun 30, 2025

ATyr Pharma, Inc.(NasdaqCM: ATYR) added to Russell Small Cap Comp Value Index - MarketScreener

Jun 30, 2025

Jun 29, 2025

ATyr Pharma, Inc.(NasdaqCM: ATYR) added to Russell 3000E Value Index - MarketScreener

Jun 29, 2025

Jun 27, 2025

Leerink Partners Sticks to Its Buy Rating for aTyr Pharma (ATYR) - The Globe and Mail

Jun 27, 2025

Jun 26, 2025

aTyr Pharma to join Russell 2000 and 3000 indexes By Investing.com - Investing.com India

Jun 26, 2025

Jun 26, 2025

aTyr Pharma to be Added to the Russell 2000® and Russell 3000® Indexes - GlobeNewswire

Jun 26, 2025

Jun 26, 2025

Clinical-Stage Biotech aTyr Pharma Secures Dual Russell Index Addition, Expanding Market Presence - Stock Titan

Jun 26, 2025

Jun 25, 2025

Is aTyr Pharma, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025

Jun 24, 2025

Kingswood Wealth Advisors LLC Sells 10,000 Shares of aTyr Pharma, Inc. (NASDAQ:ATYR) - Defense World

Jun 24, 2025

Jun 20, 2025

aTyr Pharma (ATYR) Sees Price Target Raised Amid Optimism for Ph - GuruFocus

Jun 20, 2025

Jun 20, 2025

Wells Fargo Maintains ATyr Pharma(ATYR.US) With Buy Rating, Raises Target Price to $25 - 富途牛牛

Jun 20, 2025

Jun 17, 2025

With 70% ownership, aTyr Pharma, Inc. (NASDAQ:ATYR) boasts of strong institutional backing - Yahoo Finance

Jun 17, 2025

Jun 16, 2025

Bank of America Corp DE Makes New $330,000 Investment in Atyr PHARMA INC (NASDAQ:ATYR) - MarketBeat

Jun 16, 2025

Jun 14, 2025

Cantor Fitzgerald Comments on Atyr PHARMA FY2026 Earnings - MarketBeat

Jun 14, 2025